Ketogenic Diet vs Medication for Childhood Absence Epilepsy

Overseen By Eric H Kossoff, MD

Age: < 18

Sex: Any

Trial Phase: Phase 3

Sponsor: Johns Hopkins University

Must not be taking: Anticonvulsants

Disqualifiers: Glut1 deficiency, Metabolic disorder, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Pivotal Trial (Near Approval) This treatment is in the last trial phase before FDA approval

Prior Safety Data This treatment has passed at least one previous human trial

Approved in 3 Jurisdictions This treatment is already approved in other countries

Compensation: Varies

Number of Visits: 4

Duration: 3 months

40 Participants Needed

Trial Summary

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but it excludes those who have previously used anticonvulsant drugs. It seems the trial is for children who have not yet started medication for epilepsy.

What data supports the effectiveness of the modified Atkins diet as a treatment for childhood absence epilepsy?

Research shows that the modified Atkins diet can significantly reduce seizures in children with epilepsy, including absence epilepsy. In one study, 82% of patients experienced more than a 50% reduction in seizures, and 19% became seizure-free. ^{1 2 3 4 5}

Is the modified Atkins diet safe for children with epilepsy?

The modified Atkins diet has been used for over a decade and is generally considered safe for children with epilepsy, though some may experience side effects like changes in cholesterol levels and stomach upset. ^{1 5 6 7 8}

How does the modified Atkins diet treatment differ from other treatments for childhood absence epilepsy?

The modified Atkins diet is unique because it can induce a ketotic state (a condition where the body burns fat for energy instead of carbohydrates) without the strict restrictions on calories, protein, and fluids that the traditional ketogenic diet requires. It is easier to follow and does not require hospitalization or fasting, making it more tolerable for children and adults with epilepsy. ^{1 2 9 10 11}

What is the purpose of this trial?

The ketogenic diet is a medical therapy for epilepsy that is used nearly predominantly for refractory epilepsy (after 2-3 drugs have been tried and failed). However, there is both published evidence for first-line use (infantile spasms, Glut1 deficiency syndrome) and also anecdotal experience (families choosing to change the child's (or the family' own) diet rather than use anticonvulsant medications). Childhood absence epilepsy (refractory) has been published as being responsive to ketogenic diet therapy by the investigators' group previously. This is a small, prospective, 3 month trial to assess if using a modified Atkins diet is a feasible and effective option for new-onset childhood absence epilepsy. The investigators will compare to a group of children in which the parents have declined and chose to start anticonvulsant medications.

Research Team

Eric H Kossoff, MD

Principal Investigator

Johns Hopkins University

Eligibility Criteria

This trial is for children aged 3-12 with new-onset childhood absence epilepsy, who experience daily seizures and have specific EEG patterns. They should be generally healthy or have mild disabilities. Kids who've tried a ketogenic diet, taken seizure meds before, or have certain metabolic disorders can't join.

Inclusion Criteria

My child had absence seizures start between ages 3-12.

You have average or slightly impaired intellectual abilities.

I experience daily absence seizures.

Exclusion Criteria

You are not able to follow a high fat, low carbohydrate diet.

You have had seizures in the past, except for febrile seizures.

You have a metabolic disorder that would prevent you from following a special diet.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive either the modified Atkins diet or standard drug therapy for 3 months

3 months

Visits at baseline, 1 month, and 3 months

Follow-up

Participants are monitored for safety and effectiveness after treatment

3 months

EEG and lab assessments at 3 months

Treatment Details

Interventions

• Modified Atkins Diet

Trial Overview The study is testing if a modified Atkins Diet (high fat, low carb) can help manage seizures in kids with new-onset absence epilepsy compared to those whose parents choose standard seizure medications instead.

Participant Groups

Group I: Diet therapy Experimental Treatment 1 Intervention

Modified Atkins Diet - high fat, low carbohydrate, outpatient initiated approach. Parents will check urine ketones twice weekly and follow by email, phone and clinic. Labs at baseline and 3 months. Dietitian support.

Group II: Drug therapy Active Control 1 Intervention

Families will have the usual care for absence epilepsy at the discretion of the family's neurologist and the family choice. Typically ethosuximide bis in die (BID), however, if convulsions have occurred or other factors are involved, the child may be started on valproate or lamotrigine. The child will continue medications with dose adjustment and antiseizure drug levels checked as usual. \*\*OF NOTE, THIS ARM IS COMPLETED

Modified Atkins Diet is already approved in United States, European Union, Canada for the following indications:

Approved in United States as Modified Atkins Diet for:

• Refractory epilepsy
• Childhood absence epilepsy
• Glut1 deficiency syndrome
• Infantile spasms

Approved in European Union as Modified Atkins Diet for:

• Refractory epilepsy
• Childhood absence epilepsy
• Glut1 deficiency syndrome
• Infantile spasms

Approved in Canada as Modified Atkins Diet for:

• Refractory epilepsy
• Childhood absence epilepsy
• Glut1 deficiency syndrome
• Infantile spasms

Who Is Running the Clinical Trial?

Johns Hopkins University

Lead Sponsor

Trials

2,366

Recruited

15,160,000+

Findings from Research

The modified Atkins diet, used since 2003 for treating refractory epilepsy, has shown similar effectiveness to the traditional ketogenic diet while being more tolerable for patients, with around 400 patients reported across over 30 studies.

This diet can be initiated in a clinical setting without the need for fasting or hospitalization, making it a more accessible option for both children and adults with intractable seizures.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

A decade of the modified Atkins diet (2003–2013): Results, insights, and future directions. Kossoff, EH., Cervenka, MC., Henry, BJ., et al.[2019]

In a clinical trial involving 51 children aged 1 to 16 with intractable epilepsy, the modified Atkins diet led to a significant reduction in seizure frequency, with 67% of participants experiencing over a 50% decrease after three months.

The Atkins diet was found to be a safe and well-tolerated alternative therapy, with only rare complications reported, suggesting it could be a viable option for managing refractory childhood epilepsy.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Efficacy of the Atkins diet as therapy for intractable epilepsy in children. Tonekaboni, SH., Mostaghimi, P., Mirmiran, P., et al.[2022]

In a review of 17 studies, about 69% of 133 patients with absence epilepsy experienced over a 50% reduction in seizures after following a ketogenic diet, with 34% becoming completely seizure-free.

At Johns Hopkins Hospital, both the ketogenic and modified Atkins diets showed promising results, with 82% of patients achieving over a 50% seizure reduction, and 19% becoming seizure-free, indicating these dietary therapies can be effective for managing idiopathic generalized epilepsy.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Do patients with absence epilepsy respond to ketogenic diets? Groomes, LB., Pyzik, PL., Turner, Z., et al.[2017]

A meta-analysis of 12 studies involving 270 adults with intractable epilepsy found that the classical ketogenic diet had a higher efficacy rate of 52%, compared to 34% for the modified Atkins diet, suggesting it may be more effective for seizure control.

Despite its higher efficacy, the classical ketogenic diet had a lower compliance rate of 38%, indicating that adults may find it harder to stick to compared to the modified Atkins diet, which had a compliance rate of 56%.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Efficacy of and patient compliance with a ketogenic diet in adults with intractable epilepsy: a meta-analysis. Ye, F., Li, XJ., Jiang, WL., et al.[2022]

In a study of 87 children on the modified Atkins diet for epilepsy, 55% of those who continued for over 6 months experienced more than a 50% improvement in seizures, and 35% became seizure-free after an average of 19.9 months.

The diet showed similar efficacy to short-term studies and long-term ketogenic diets, but side effects included increased lipid levels and gastrointestinal issues, indicating the need for monitoring during treatment.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Long-term follow-up of children treated with the modified Atkins diet. Chen, W., Kossoff, EH.[2017]

The modified Atkins diet, a less restrictive version of the ketogenic diet, has shown good efficacy and tolerability in treating refractory epilepsy, making it a promising dietary intervention.

This diet can be initiated on an outpatient basis without fasting, allowing unlimited protein and fat intake, which may improve adherence compared to more restrictive diets.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

The modified atkins diet in refractory epilepsy. Sharma, S., Jain, P.[2022]

The modified Atkins diet (MAD) was tested in a prospective study involving five children aged 4-18 years with Sturge-Weber syndrome, showing promising results in managing intractable seizures over a 6-month period.

All participants achieved urinary ketosis and experienced improvements in seizure frequency, with three children reporting more than a 50% reduction in seizures, suggesting that MAD may be a safer alternative to the ketogenic diet for this population.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

A pilot study of the modified Atkins diet for Sturge-Weber syndrome. Kossoff, EH., Borsage, JL., Comi, AM.[2010]

In a study involving four adult patients with drug-resistant epilepsy, the modified Atkins diet led to a significant average reduction of 35% in serum concentrations of antiepileptic drugs (AEDs) after 12 weeks, indicating a potential pharmacokinetic interaction.

This reduction in AED levels could have clinical implications for patients, suggesting that careful monitoring of AED serum concentrations is necessary when implementing the modified Atkins diet as an add-on therapy.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Modified Atkins diet may reduce serum concentrations of antiepileptic drugs. Kverneland, M., Taubøll, E., Selmer, KK., et al.[2018]

The Atkins diet, which is less restrictive than the traditional ketogenic diet, was tested on six patients with intractable epilepsy, showing that five of them maintained a state of ketosis for 6 weeks to 24 months.

Three patients experienced a reduction in seizures and were able to lower their antiepileptic medications, suggesting that the Atkins diet may be a promising alternative therapy for those with epilepsy that does not respond to standard treatments.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Efficacy of the Atkins diet as therapy for intractable epilepsy. Kossoff, EH., Krauss, GL., McGrogan, JR., et al.[2022]

In a study of 30 adults with intractable epilepsy, the modified Atkins diet led to a significant reduction in seizures, with 47% of participants experiencing over a 50% reduction in seizures after 1 and 3 months.

The diet was associated with a mean weight loss of 6.8 kg, and those who lost weight showed better seizure control, although some participants experienced side effects like increased cholesterol and a high discontinuation rate of 30%.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

A prospective study of the modified Atkins diet for intractable epilepsy in adults. Kossoff, EH., Rowley, H., Sinha, SR., et al.[2022]

A clinical trial involving 40 children with intractable epilepsy found that both the classic ketogenic diet and the modified Atkins diet resulted in similar efficacy, with over 50% reduction in seizures observed in both groups at various time points.

Specifically, the response rates for the ketogenic diet were 55%, 30%, and 70% at the end of the first, second, and third months, while the Atkins diet showed 50%, 65%, and 70% at the same intervals, indicating that both diets are effective options for managing seizures in children.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

The ketogenic and atkins diets effect on intractable epilepsy: a comparison. Ghazavi, A., Tonekaboni, SH., Karimzadeh, P., et al.[2021]

References

1. United States pubmed.ncbi.nlm.nih.gov

A decade of the modified Atkins diet (2003–2013): Results, insights, and future directions. [2019]

2. Iran pubmed.ncbi.nlm.nih.gov

Efficacy of the Atkins diet as therapy for intractable epilepsy in children. [2022]

3. United States pubmed.ncbi.nlm.nih.gov

Do patients with absence epilepsy respond to ketogenic diets? [2017]

4. Korea (South) pubmed.ncbi.nlm.nih.gov

Efficacy of and patient compliance with a ketogenic diet in adults with intractable epilepsy: a meta-analysis. [2022]

5. United States pubmed.ncbi.nlm.nih.gov

Long-term follow-up of children treated with the modified Atkins diet. [2017]

6. United States pubmed.ncbi.nlm.nih.gov

The modified atkins diet in refractory epilepsy. [2022]

7. Netherlands pubmed.ncbi.nlm.nih.gov

A pilot study of the modified Atkins diet for Sturge-Weber syndrome. [2010]

8. Denmark pubmed.ncbi.nlm.nih.gov

Modified Atkins diet may reduce serum concentrations of antiepileptic drugs. [2018]

9. United States pubmed.ncbi.nlm.nih.gov

Efficacy of the Atkins diet as therapy for intractable epilepsy. [2022]

10. United States pubmed.ncbi.nlm.nih.gov

A prospective study of the modified Atkins diet for intractable epilepsy in adults. [2022]

11. Iran pubmed.ncbi.nlm.nih.gov

The ketogenic and atkins diets effect on intractable epilepsy: a comparison. [2021]